Anondita Medicare IPO will open on August 22, 2025 and close on August 26, 2025. It is a Book Built Issue through which the company plans to raise about ₹69.50 crores, comprising a fresh issue of ₹69.50 crores and an offer for sale of up to [.] equity shares with a face value of ₹10 each.

The price band for the IPO is fixed at ₹137 to ₹145 per share. The quota distribution is 35% for retail investors, 50% for QIBs, and 15% for HNIs. The IPO is scheduled to list on the NSE SME platform on September 1, 2025, while the allotment date is set for August 28, 2025.

Financially, the company posted a revenue of ₹77.13 crores in 2025 compared to ₹46.56 crores in 2024, and a profit of ₹16.42 crores in 2025 against ₹3.84 crores in 2024. Based on these numbers, investors are advised to consider this IPO for the long term.

About Anondita Medicare IPO

Anondita Medicare Limited, incorporated in March 2024, is one of the growing companies involved in the manufacturing of flavored male condoms under its main brand, “COBRA.” The company has an annual production of 562 million condoms. Its manufacturing units are situated in Noida, Uttar Pradesh. Anondita Medicare exports its products to Southeast Asia, Africa, and the Middle East. Anondita Medicare Limited is involved in working with global health groups, NGOs, and governments in order to promote family planning and public health. The company also holds a strong distribution network that delivers its products on time to different markets.

Anondita Medicare partners with wholesalers, retailers, and e-commerce platforms with the aim of making products easily available to everyone. The company includes 280 employees as of July 31, 2025. Moreover, the company also partners with overnment health programs in order to supply essential medical products.